Cellular pharmacodynamics of anticancer drugs
Plunkett, W.; Gandhi, V.
Seminars in Oncology 20(1): 50-63
1993
ISSN/ISBN: 0093-7754 PMID: 8475410 Document Number: 411026
Document emailed within 1 workday
Related Documents
Ohtsu, T.; Sasaki, Y. 1993: Pharmacodynamics of anticancer agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(12): 1741-1749Egorin, M.J.; Clawson, R.E.; Cohen, J.L.; Ross, L.A.; Bachur, N.R. 1979: Cellular pharmacology of 7(R)-O-methylnogarol: a new anticancer agent Journal of Pharmacology and Experimental Therapeutics 210(2): 229-236
Valeriote, F.; Lin, H.s. 1975: Synergistic interaction of anticancer agents: a cellular perspective Cancer ChemoTherapy Reports 59(5): 895-900
Suhara, T. 2007: Molecular imaging for pharmacodynamics of psychotropic drugs Seishin Shinkeigaku Zasshi 109(9): 869-875
Bénard, J.; Rixe, O. 1996: Resistance to anticancer drugs Presse Medicale 25(35): 1724-1730
Ben Aïssa, A.; George, A-C.; El M'Rabet, F.Z.; Mach, N.; Dietrich, P-Y.; Pechère-Bertschi, A. 2011: Anticancer drugs under pressure Revue Medicale Suisse 7(308): 1761-1766
Rosenthal, R.C.; Michalski, D. 1991: Storage of expensive anticancer drugs Journal of the American Veterinary Medical Association 198(1): 144-146
Young, R.S. 1979: Problems of toxicity of anticancer drugs Federation Proceedings 38(1): 113-114
Fattoruso, S.I.S.; Di Lauro, L.; Conti, F.; Amodio, A.; Lopez, M. 2008: Target selectivity of anticancer drugs La Clinica Terapeutica 159(3): 189-206
Netter, P.; Bannwarth, B.; Lapicquel, F.; Demotes-Mainard, F.; Schceverbeke, T.; Gillet, P. 1993: Pharmacokinetics and pharmacodynamics of non steroidal anti-inflammatory drugs in synovial fluid Agents and Actions. Supplements 44: 45-50
Smirennaia, E.V.; Maĭchuk, D.I.; Kurenkov, V.V. 2002: Characteristics of pharmacodynamics of drugs after excimer laser surgery (an experimental study) Vestnik Oftalmologii 118(3): 32-35
Belpaire, F. 1987: Effect of inflammation on blood protein binding, pharmacokinetics and pharmacodynamics of drugs Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 49(1): 83-97
Jullien, V.; Lortholary, O. 2006: Pharmacokinetics-pharmacodynamics of antifungal drugs. Consequences for therapeutic drug monitoring Therapie 61(3): 209-217
Piuhola, J.; Tenhunen, O.; Kerkelä, R. 2015: Adverse cardiac effects associated with anticancer drugs Duodecim; Laaketieteellinen Aikakauskirja 131(5): 441-447
Schmähl, D. 1986: Carcinogenicity of anticancer drugs and especially alkylating agents Iarc Scientific Publications 78: 29-35
Ogawa, M. 1983: Current clinical status of new anticancer drugs Gan no Rinsho. Japan Journal of Cancer Clinics 29(10): 1049-1052
Tsukagoshi, S. 1993: Recent development of new anticancer drugs in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 51(7): 1923-1929
Mielens, Z.E.; Connolly, K.; Stecher, V.J. 1985: Effect of disease modifying antirheumatic drugs and nonsteroidal antiinflammatory drugs upon cellular and fibronectin responses in a pleurisy model Journal of Rheumatology 12(6): 1083-1087
Collins, J.M. 1988: Improving the use of anticancer drugs: clinical pharmacokinetic approaches Israel Journal of Medical Sciences 24(9-10): 483-487
Gokhale, S.V.; Ganu, U.K.; Ambaye, R.Y. 1985: Effects of anticancer drugs on folate disposition and excretion Journal of Postgraduate Medicine 31(3): 123-127